Cite

HARVARD Citation

    Rodriguez Villalba, S. et al. (n.d.). EP-2269: Survial Endpoints Comparing HDR BT Boost To EBRT Boost For High/Intermediate-Risk Prostate Cancer. Radiotherapy and oncology. pp. S1253-. [Online]. 
  
Back to record